Caltrate 600 with D Plus Soy Interactions
There are 270 drugs known to interact with Caltrate 600 with D Plus Soy (calcium / vitamin d), along with 11 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 17 are major, 200 are moderate, and 53 are minor.
- View all 270 medications that may interact with Caltrate 600 with D Plus Soy
- View Caltrate 600 with D Plus Soy alcohol/food interactions (1)
- View Caltrate 600 with D Plus Soy disease interactions (11)
Most frequently checked interactions
View interaction reports for Caltrate 600 with D Plus Soy (calcium / vitamin d) and the medicines listed below.
- abacavir / dolutegravir / lamivudine
- Aciphex (rabeprazole)
- Actonel (risedronate)
- Actos (pioglitazone)
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- alendronate
- Allegra Allergy (fexofenadine)
- alprazolam
- Aspirin Low Strength (aspirin)
- Centrum Silver (multivitamin with minerals)
- CoQ10 (ubiquinone)
- Crestor (rosuvastatin)
- Diovan (valsartan)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- hydrochlorothiazide
- levothyroxine
- metoprolol
- Metoprolol Succinate ER (metoprolol)
- omeprazole
- Plavix (clopidogrel)
- pravastatin
- simvastatin
- tramadol
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- vitamin e
- Xanax (alprazolam)
- Zantac (ranitidine)
- Zyrtec (cetirizine)
Caltrate 600 with D Plus Soy alcohol/food interactions
There is 1 alcohol/food interaction with Caltrate 600 with D Plus Soy (calcium / vitamin d).
Caltrate 600 with D Plus Soy disease interactions
There are 11 disease interactions with Caltrate 600 with D Plus Soy (calcium / vitamin d) which include:
- cardiovascular adverse effects
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- hepatobiliary dysfunction
Report options
More about Caltrate 600 with D Plus Soy (calcium / vitamin d)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
